Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

0.000p
   
  • Closing Price Chg:
    -10.00p
  • 52 Week High: 2,715.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 0
  • RiskGrade: 128
  • Beta: 0.02

Latest ShareCast News

London close: Stocks maintain gains after weak US payrolls

By Josh White

Date: Thursday 04 Sep 2025

(Sharecast News) - London stocks ended higher on Thursday as investors weighed weaker US labour market data against sector-specific losses in airlines.

Genus ShareCast News

Genus shares surge on strong FY results, China a... 04-Sep-2025 ShareCast
Genus delivers 'strong' underlying group trading... 15-Jul-2025 ShareCast
London close: Stocks finish higher as US economy... 30-Apr-2025 ShareCast
Genus taps Andy Russell for CFO 13-Mar-2025 ShareCast
Genus's bottom line hit by write-downs 27-Feb-2025 ShareCast

Genus Regulatory News

Director/PDMR Shareholding 19-Sep-2025 14:39 RNS
Director/PDMR Shareholding 17-Sep-2025 12:14 RNS
Director/PDMR Shareholding 11-Sep-2025 12:20 RNS
Additional Listing 08-Sep-2025 16:05 RNS
Preliminary results 04-Sep-2025 07:00 RNS

Genus Newspaper Links

GENUS PROFIT BOOSTED 07-Sep-2011 Express & Star
Genus shares jump on bid talk 20-May-2008 The Scotsman
SLI’s high flyer pushes toward UK’s top slot 24-Dec-2007 The Herald
Extra security 07-Aug-2007 The Scotsman
Look ahead 16-Sep-2006 Times

Genus Tips & Analysis

Investment Column:Genus 09-Sep-2011 The Independent
Investment Column:Genus 05-Jul-2011 The Independent
Questor : Genus 02-Jun-2011 Telegraph
Questor:Genus 24-Feb-2011 Telegraph
FTSE close: Barclays down; Invensys, Tullow Oil up 08-Sep-2010 Daily Mail

Genus News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,440.00p
Closing Price Change -10.00p
% Change 0.00 %
52 Week High 2,715.00
52 Week Low 1,424.00
Volume 0
Shares Issued 66.54m
Beta 0.02
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 23-Sep-2025

Time Volume / Share Price
14:47 7 @ 2,390.00p
14:44 140 @ 2,387.50p
14:44 5 @ 2,385.00p
14:44 55 @ 2,385.00p
14:40 24 @ 2,380.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page